Allergy News and Research

RSS

The term allergy encompasses a wide range of conditions; it is not a disease in itself. In 1906 Clemens von Pirquet was the first to describe allergies as a changed or altered reaction of the immune system in response to exposure to foreign proteins. These days the term allergy – medically termed hypersensitivity, signifies an exaggerated reaction to foreign substances.

Seasonal flu vaccine offers some protection from H5N1

The yearly influenza vaccine that health officials urge people to get each fall might also offer certain individuals some cross protection against the H5N1 virus commonly known as bird flu, according to investigators at St. Jude Children's Research Hospital.

13 Feb 2007

Researchers discover why antipsychotic drugs cause weight gain

Researchers at Johns Hopkins University in Baltimore have discovered why some drugs used to treat mental illnesses such as schizophrenia, cause patients to gain a lot of weight.

13 Feb 2007

Healthier wines

A new technique that uses ozone to preserve grapes could help prevent allergies and boost healthy compounds at the same time, reports Jennifer Rohn in Chemistry & Industry, the magazine of the Society of Chemical Industry.

12 Feb 2007

FDA approves absorbable polymer suture that uses DNA technology

The U.S. Food and Drug Administration (FDA) has announced it has cleared for marketing in the U.S. the TephaFLEX Absorbable Suture - the first absorbable polymer suture made from material isolated from bacteria modified by recombinant DNA technology.

12 Feb 2007

South Africa starts major HIV/AIDS vaccine trial

The launch of the first large-scale study to evaluate a candidate HIV vaccine on the African continent was announced today by study collaborators in the United States and South Africa. The trial will involve up to 3,000 participants at five sites throughout South Africa and is expected to continue for four years.

11 Feb 2007

Hair dye allergies increasing

Allergic reactions to hair dye are increasing as more and younger people dye their hair, warn researchers in this week's British Medical Journal.

5 Feb 2007

Different treatments may be needed for chronic asthma, depending on whether it results from allergies or lung infections

Researchers have now identified a particular gene that influences how severe a M. pneumoniae infection may be, which in turn suggests that a different strategy might be needed for treating asthma resulting from this and similar lung infections rather than allergies.

31 Jan 2007

Cellular mechanism linked to inflammation and cancer

A team led by biochemists at the University of California, San Diego has found what could be a long-elusive mechanism through which inflammation can promote cancer. The findings may provide a new approach for developing cancer therapies.

28 Jan 2007

Human immune system has not adapted to changes in the environment

It seems that the current "allergy epidemic" is due not so much to an increase in allergenic risk factors as to the disappearance of factors protecting people against allergies.

25 Jan 2007

Inhaled steroids best treatment for children with asthma

Although several medications are available to help children maintain asthma control, clinical trials directly comparing them have not been conducted.

23 Jan 2007

Heska to sell allergy patents to Allergopharma

Heska Corporation has announced that it has completed the sale of its rights in a worldwide patent portfolio covering a number of major allergens and the genes that encode them to Allergopharma Joachim Ganzer KG for an undisclosed sum.

22 Jan 2007

Sequella receives FDA fast track status for pulmonary tuberculosis drug

Sequella, Inc. has announced it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for SQ109, the company's proprietary lead drug candidate for treatment of pulmonary tuberculosis (TB).

22 Jan 2007

Lung neutrophils produce histamine in significant quantities

In a surprise finding, scientists have discovered that histamine, the inflammatory compound released during allergic reactions that causes runny nose, watery eyes, and wheezing, can be produced in large amounts in the lung by neutrophils, the white blood cells that are the major component of pus.

14 Jan 2007

Race to accelerate tuberculosis drug development

Each year, tuberculosis kills nearly two million people while an estimated nine million develop the disease -- with the hardest-hit areas in AIDS-afflicted developing nations.

14 Jan 2007

Allergic reactions to insulin have declined and Continuous Subcutaneous Insulin Infusion could reduce them further

A review of published research from the University of Liege, Belgium, reveals a decline in the number of people experiencing allergic reactions to insulin. This is largely due to better purification of animal insulin and the introduction of human recombinant insulin.

8 Jan 2007

DNA vaccine for H5N1 avian influenza enters human trial

The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD.

3 Jan 2007

An effective malaria vaccine by 2025

A report by the world's leading international health organizations today calls for joint action to accelerate the development and licensing of a highly effective malaria vaccine.

4 Dec 2006

The role of gut worms in allergies

Gut parasites could hold the key to increasingly common conditions such as eczema, asthma and hay fever, according to scientists at The University of Nottingham.

2 Dec 2006

New approaches to expanding HIV testing

Nearly 300 U.S. physicians, government health officials and HIV/AIDS advocates on Wednesday gathered in Washington, D.C., for a two-day meeting that focuses on new approaches to expanding HIV testing in the nation and its potential effect on the health system, Reuters Health reports.

2 Dec 2006

Interruptions in antiretroviral treatment increases risk of developing AIDS-related diseases

Interruptions in an HIV-positive person's antiretroviral treatment regimen can increase the risk of developing AIDS-related diseases and sometimes can be fatal, according to a study published Thursday in the New England Journal of Medicine, the Los Angeles Times reports.

2 Dec 2006